Pharmachal Health Group has elected to list on the SSX as a stepping-stone towards listing on a major international exchange.
Charles Fridlender, Founder and Executive Director said, " As a fast-growing company we want to direct as much attention and funds towards our international product rollout and don’t need the costs or burden of excessive compliance of a major exchange just yet. The SSX has the right balance between ensuring compliance and letting businesses do business.”
The company saw the SSX's access into exchanges in Germany, USA and the UK as potentially very useful. Investors should contact the company or Ricard Securities for more information.
See the SSX's newsletter announcing PHG's intention to list.
SSX Newsletter 062021[19157]
.pdf
Download PDF • 872KB